Cytokinetics, Inc. (CYTK)
77.09
+0.25
(+0.33%)
USD |
NASDAQ |
Aug 24, 16:00
77.09
0.00 (0.00%)
After-Hours: 20:00
Cytokinetics Total Assets (Quarterly) : 1.925B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.925B |
| March 31, 2026 | 1.273B |
| December 31, 2025 | 1.425B |
| September 30, 2025 | 1.437B |
| June 30, 2025 | 1.226B |
| March 31, 2025 | 1.264B |
| December 31, 2024 | 1.402B |
| September 30, 2024 | 1.436B |
| June 30, 2024 | 1.524B |
| March 31, 2024 | 808.08M |
| December 31, 2023 | 824.32M |
| September 30, 2023 | 740.61M |
| June 30, 2023 | 779.90M |
| March 31, 2023 | 889.82M |
| December 31, 2022 | 1.015B |
| September 30, 2022 | 1.076B |
| June 30, 2022 | 771.72M |
| March 31, 2022 | 856.25M |
| December 31, 2021 | 841.32M |
| September 30, 2021 | 827.54M |
| June 30, 2021 | 564.30M |
| March 31, 2021 | 577.06M |
| December 31, 2020 | 533.80M |
| September 30, 2020 | 474.11M |
| June 30, 2020 | 232.50M |
| Date | Value |
|---|---|
| March 31, 2020 | 256.58M |
| December 31, 2019 | 289.81M |
| September 30, 2019 | 187.39M |
| June 30, 2019 | 198.22M |
| March 31, 2019 | 198.61M |
| December 31, 2018 | 211.18M |
| September 30, 2018 | 230.28M |
| June 30, 2018 | 247.24M |
| March 31, 2018 | 279.93M |
| December 31, 2017 | 294.81M |
| September 30, 2017 | 326.31M |
| June 30, 2017 | 340.63M |
| March 31, 2017 | 265.37M |
| December 31, 2016 | 170.14M |
| September 30, 2016 | 158.17M |
| June 30, 2016 | 106.16M |
| March 31, 2016 | 113.22M |
| December 31, 2015 | 115.24M |
| September 30, 2015 | 102.20M |
| June 30, 2015 | 112.71M |
| March 31, 2015 | 122.21M |
| December 31, 2014 | 132.97M |
| September 30, 2014 | 87.18M |
| June 30, 2014 | 96.14M |
| March 31, 2014 | 107.28M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 1.501B |
| Ionis Pharmaceuticals, Inc. | 2.995B |
| Bristol Myers Squibb Co. | 87.63B |
| Gilead Sciences, Inc. | 49.36B |
| Rigel Pharmaceuticals, Inc. | 521.07M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.098B |
| Shareholders Equity (Quarterly) | -173.49M |
| Debt to Equity Ratio | -7.324 |
| Current Ratio | 6.661 |
| Net Debt Paydown Yield | -0.81% |